The contribution of whole-exome sequencing to intellectual disability diagnosis and knowledge of underlying molecular mechanisms: A systematic review and meta-analysis

IF 6.4 2区 医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Mutation Research-Reviews in Mutation Research Pub Date : 2022-07-01 DOI:10.1016/j.mrrev.2022.108428
Karen Y. Sánchez-Luquez , Marina Xavier Carpena , Simone M. Karam , Luciana Tovo-Rodrigues
{"title":"The contribution of whole-exome sequencing to intellectual disability diagnosis and knowledge of underlying molecular mechanisms: A systematic review and meta-analysis","authors":"Karen Y. Sánchez-Luquez ,&nbsp;Marina Xavier Carpena ,&nbsp;Simone M. Karam ,&nbsp;Luciana Tovo-Rodrigues","doi":"10.1016/j.mrrev.2022.108428","DOIUrl":null,"url":null,"abstract":"<div><p><span>Whole-exome sequencing (WES) is useful for molecular diagnosis, family genetic counseling<span>, and prognosis of intellectual disability (ID). However, ID molecular diagnosis ascertainment based on WES is highly dependent on </span></span><em>de novo</em><span> mutations (DNMs) and variants of uncertain significance (VUS). The quantification of DNM frequency<span><span> in ID molecular diagnosis ascertainment and the biological mechanisms common to genes with VUS may provide objective information about WES use in ID diagnosis and etiology. We aimed to investigate and estimate the rate of ID molecular diagnostic assessment by WES, quantify the contribution of DNMs to this rate, and biologically and functionally characterize the genes whose mutations were identified through WES. A PubMed/Medline, Web of Science, Scopus, Science Direct, BIREME, and </span>PsycINFO<span> systematic review and meta-analysis was performed, including studies published between 2010 and 2022. Thirty-seven articles with data on ID molecular diagnostic yield using the WES approach were included in the review. WES testing accounted for an overall diagnostic rate of 42% (Confidence interval (CI): 35–50%), while the estimate restricted to DNMs was 11% (CI: 6–18%). Genetic<span> information on mutations and genes was extracted and split into two groups: (1) genes whose mutation was used for positive molecular diagnosis, and (2) genes whose mutation led to uncertain molecular diagnosis. After functional enrichment analysis, in addition to their expected roles in neurodevelopment<span><span>, genes from the first group were enriched in epigenetic regulatory mechanisms, immune system regulation, and circadian rhythm control. Genes from uncertain diagnosis cases were enriched in the renin </span>angiotensin pathway. Taken together, our results support WES as an important approach to the molecular diagnosis of ID. The results also indicated relevant pathways that may underlie the pathogenesis of ID with the renin-angiotensin pathway being suggested to be a potential pathway underlying the pathogenesis of ID.</span></span></span></span></span></p></div>","PeriodicalId":49789,"journal":{"name":"Mutation Research-Reviews in Mutation Research","volume":"790 ","pages":"Article 108428"},"PeriodicalIF":6.4000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mutation Research-Reviews in Mutation Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1383574222000187","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 11

Abstract

Whole-exome sequencing (WES) is useful for molecular diagnosis, family genetic counseling, and prognosis of intellectual disability (ID). However, ID molecular diagnosis ascertainment based on WES is highly dependent on de novo mutations (DNMs) and variants of uncertain significance (VUS). The quantification of DNM frequency in ID molecular diagnosis ascertainment and the biological mechanisms common to genes with VUS may provide objective information about WES use in ID diagnosis and etiology. We aimed to investigate and estimate the rate of ID molecular diagnostic assessment by WES, quantify the contribution of DNMs to this rate, and biologically and functionally characterize the genes whose mutations were identified through WES. A PubMed/Medline, Web of Science, Scopus, Science Direct, BIREME, and PsycINFO systematic review and meta-analysis was performed, including studies published between 2010 and 2022. Thirty-seven articles with data on ID molecular diagnostic yield using the WES approach were included in the review. WES testing accounted for an overall diagnostic rate of 42% (Confidence interval (CI): 35–50%), while the estimate restricted to DNMs was 11% (CI: 6–18%). Genetic information on mutations and genes was extracted and split into two groups: (1) genes whose mutation was used for positive molecular diagnosis, and (2) genes whose mutation led to uncertain molecular diagnosis. After functional enrichment analysis, in addition to their expected roles in neurodevelopment, genes from the first group were enriched in epigenetic regulatory mechanisms, immune system regulation, and circadian rhythm control. Genes from uncertain diagnosis cases were enriched in the renin angiotensin pathway. Taken together, our results support WES as an important approach to the molecular diagnosis of ID. The results also indicated relevant pathways that may underlie the pathogenesis of ID with the renin-angiotensin pathway being suggested to be a potential pathway underlying the pathogenesis of ID.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
全外显子组测序对智力残疾诊断和潜在分子机制知识的贡献:系统综述和荟萃分析
全外显子组测序(WES)在智力残疾(ID)的分子诊断、家庭遗传咨询和预后预测方面具有重要意义。然而,基于WES的ID分子诊断高度依赖于新生突变(dnm)和不确定意义变异(VUS)。DNM频率在ID分子诊断中的量化及VUS基因共有的生物学机制可为WES在ID诊断和病因学中的应用提供客观信息。我们的目的是调查和估计通过WES进行ID分子诊断评估的比率,量化dnm对该比率的贡献,并对通过WES鉴定出突变的基因进行生物学和功能表征。对PubMed/Medline、Web of Science、Scopus、Science Direct、BIREME和PsycINFO进行了系统回顾和荟萃分析,包括2010年至2022年间发表的研究。本文纳入了37篇采用WES方法的ID分子诊断产率数据。WES检测占总诊断率42%(置信区间(CI): 35-50%),而仅限于dnm的估计为11% (CI: 6-18%)。提取突变和基因的遗传信息,并将其分为两组:(1)突变用于阳性分子诊断的基因,(2)突变导致不确定分子诊断的基因。经过功能富集分析,第一组基因除了在神经发育中发挥预期作用外,还富集了表观遗传调控机制、免疫系统调控和昼夜节律控制。来自不确定诊断病例的基因在肾素血管紧张素途径中富集。综上所述,我们的结果支持WES作为ID分子诊断的重要方法。这些结果还提示了可能导致ID发病的相关途径,其中肾素-血管紧张素途径被认为是ID发病的潜在途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
12.20
自引率
1.90%
发文量
22
审稿时长
15.7 weeks
期刊介绍: The subject areas of Reviews in Mutation Research encompass the entire spectrum of the science of mutation research and its applications, with particular emphasis on the relationship between mutation and disease. Thus this section will cover advances in human genome research (including evolving technologies for mutation detection and functional genomics) with applications in clinical genetics, gene therapy and health risk assessment for environmental agents of concern.
期刊最新文献
Emerging pollutants in the aquatic environments: A review of genotoxic impacts State of art of micronuclei assay in exfoliative cytology as a clinical biomarker of genetic damage in oral carcinogenesis: A systematic review and meta-analysis A critical review of the impact of candidate copy number variants on autism spectrum disorder Use of micronucleus cytome assays with buccal cells for the detection of genotoxic effects: A systematic review and meta-analysis of occupational exposures to metals Genome-scale mutational signature analysis in fixed archived tissues
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1